According to AlphaMoat, in 2026-08 Noah AI (noahai.co) received 677 monthly visits (-78.3% MoM) — ranked #16,689 of 17,406 AI websites with traffic data, and #2,976 of 3,146 in Industry Services; its largest market is India (55.1% of visits).
Noah is a domain-specific AI agent built for pharmaceutical and medical professionals, producing documented, decision-supporting reports based on PubMed, clinical guidelines, patents, and professional databases, covering drug development, pipeline valuation, and sales forecasting. Noah first clarifies scope and assumptions, then routes to the best model and tools to retrieve and synthesize evidence, generating cited tables and key findings, and performing coverage checks to flag missing evidence.
Usage-based on credits: the free tier is US$ 0 (with 300 credits on first registration); the Starter annual plan is US$ 148.8 (equivalent to US$12.40/month, 600 credits per month); the Pro annual plan is US$ 499.2 (equivalent to US$41.60/month, 2,000 credits); the Elite annual plan is US$ 1999.2 (equivalent to US$166.60/month, 10,000 credits), with a discount for annual payment.
Data month: 2026-08 · Visit figures are third-party traffic estimates aggregated monthly — best for scale and trends. Multiple domains of the same product are merged. See methodology.